Cronos Group Inc Quick Ratio (CRON) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cronos Group Inc   (NASDAQ: CRON)

Cronos Group Inc 's Quick Ratio

CRON's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 10.97 below Cronos Group Inc average.

Within Legal Cannabis industry Cronos Group Inc booked the highest Quick Ratio than Cronos Group Inc in the third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 146 to 284.

Explain Quick Ratio?
How much Cash & cash equivalents CRON´s has?
What are CRON´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CRON/financial-strength
https://api.csimarket.com/api/v1/companies/CRON/fundamentals
https://api.csimarket.com/api/v1/companies/CRON/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CRON Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 66.94 %
Y / Y Cash & cash equivalent Change -10.07 %
Quick Ratio MRQ 10.97
CRON's Total Ranking # 284
Seq. Current Liabilities Change 19.92 %
Seq. Cash & cash equivalent Change -7.01 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Legal Cannabis Industry # 1
Consumer Non Cyclical Sector # 5
Overall Market # 284


Quick Ratio Statistics
High Average Low
31.43 15.88 0.72
(Jun 30 2023)   0




Financial Statements
Cronos Group Inc 's Current Liabilities $ 68 Millions Visit CRON's Balance sheet
Cronos Group Inc 's Cash & cash equivalent $ 741 Millions Visit CRON's Balance sheet
Source of CRON's Sales Visit CRON's Sales by Geography


Cumulative Cronos Group Inc 's Quick Ratio

CRON's Quick Ratio for the trailling 12 Months

CRON Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 35.75 %
Y / Y Cash & cash equivalent TTM Growth -4.87 %
Quick Ratio TTM 14.77
Total Ranking TTM # 3026
Seq. Current Liabilities TTM Growth 14.34 %
Seq. Cash & cash equivalent TTM Growth -2.53 %


On the trailing twelve months basis Due to increase in Current Liabilities in the Q3 2026 to $67.59 millions, cumulative Quick Ratio decreased to 14.77 above the CRON average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Legal Cannabis industry 11 other companies have achieved higher Quick Ratio than Cronos Group Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2318 to 3026.

Explain Quick Ratio?
How much Cash & cash equivalents CRON´s has?
What are CRON´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Legal Cannabis Industry # 12
Consumer Non Cyclical Sector # 93
Within the Market # 3026


trailing twelve months Quick Ratio Statistics
High Average Low
26.18 14 0.9
(Dec 31 2023)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Legal Cannabis Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Definium Therapeutics Inc   15.46 $ 1,046.848  Millions$ 67.730  Millions
Cronos Group Inc   10.97 $ 741.174  Millions$ 67.594  Millions

Date modified: 2026-11-06T13:01:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.